Form4insider filings, from the source

SEC Form 4 · accession 0000921895-16-006268

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Oct 25, 2016
Accepted (ET)
Dec 2, 2016 · 6:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Oct 25, 2016L6$6.51A66,791IBy: Separately Managed Account
Common StockF1,F5Oct 27, 2016L1$6.51A66,792IBy: Separately Managed Account
Common StockF1,F5Nov 15, 2016L3$6.51A66,795IBy: Separately Managed Account
Common StockF1,F5Nov 22, 2016L23$6.51A66,818IBy: Separately Managed Account
Common StockF1,F5Nov 25, 2016L2$6.51A66,820IBy: Separately Managed Account
Common StockF1,F5Nov 29, 2016L35$6.51A66,855IBy: Separately Managed Account
Common StockF1,F5Nov 30, 2016P807$6.51A67,662IBy: Separately Managed Account
Common StockF1,F5Dec 2, 2016P1$6.51A67,663IBy: Separately Managed Account
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses